Cargando…
Efficacy and safety profile of Glucagon-Like Peptide-1 Receptor Agonist in obese Type-2 diabetes patients from a private institution in Karachi
OBJECTIVE: To assess the effectiveness of GLP-1RAs in managing obese T2DM patients. METHODS: This prospective cohort analysis was conducted at Medicell Institute of Diabetes, Karachi, Pakistan; from July 2019 to July 2021. A total of 97 obese individuals >16 years of age with T2DM and IGT were in...
Autores principales: | Qasim, Saeeda Fouzia, Ahsan, Tasnim, Ghaus, Saima, Imran, Paras |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Professional Medical Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364304/ https://www.ncbi.nlm.nih.gov/pubmed/37492314 http://dx.doi.org/10.12669/pjms.39.4.7353 |
Ejemplares similares
-
SGLT 2 Inhibitors; glycemic control, weight loss and safety profile in patients with type 2 Diabetes, at Medicell Institute (MIDEM)
por: Sohail, Erum, et al.
Publicado: (2021) -
Frequency of Metabolic Syndrome in Chronic Hepatitis C Patients: Findings From a Lower Middle Income Country
por: Qasim, Saeeda Fouzia, et al.
Publicado: (2020) -
Burden of Elevated Body Mass Index and Its Association With Non-Communicable Diseases in Patients Presenting to an Endocrinology Clinic
por: Ghaus, Saima, et al.
Publicado: (2021) -
The molecular pharmacology of glucagon agonists in diabetes and obesity
por: Novikoff, Aaron, et al.
Publicado: (2023) -
Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
por: Lee, Seungah, et al.
Publicado: (2017)